Abstract
In 1926 Maximilian Stern introduced a new instrument to treat obstructions at the vesical orifice and baptized it resectoscope. With reference to astonishing historical statements about the new instrument and surgical technique made by the pioneers and their critics we will value why transurethral resection of the prostate (TURP) remains the gold standard for most men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic enlargement. TURP is currently challenged by recently introduced new instruments and techniques claiming advantages over TURP. However, TURP offers an excellent balance between high efficacy in symptom relieve and low morbidity along with low costs and favorable long term outcome compared to other treatment options. We will outline these arguments demonstrating that even after a century has elapsed, since its introduction into the urologists armamentarium, TURP continues to stand the passage of time.
Similar content being viewed by others
References
Stern M (1926) Resection of obstructions at the vesical orifice. JAMA 87(14):1726–1730
Davis TM (1931) Prostate operation. Prospects of the patient with prostatic disease in prostatectomy vs resection. JAMA 97(19):1674–1679
McCarthy A (1931) A new apparatus for endoscopic plastic surgery of the prostate, diathermia and excision of vesical growths. J Urol 26(5):695–696
Martin HW, Day RV, Kutzmann AA (1932) Cysto-urethroscopic resection of the prostate. Cal West Med 36(2):76–79
EAU Guidelines (2020) Edn presented at the EAU Annual Congress Amsterdam 2020. ISBN 978-94-92671-07-3. https://uroweb.org/guideline/treatment-of-non-neurogenic-mal-luts. Accessed 14 Sept 2020
Parsons JK, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, Lerner LB, Roehrborn CG, Stoffel JT, Welliver C, Wilt TJ, McVary KT (2020) Surgical Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. http://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(bph)-guideline. Accessed 14 Sept 2020
Gilfrich C, Leicht H, Fahlenbrach C, Jeschke E, Popken G, Stolzenburg JU, Weissbach L, Zastrow C, Günster C (2016) Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95577 cases from a nationwide German health insurance database. Prostate Cancer Prostatic Dis 19(4):406–411
Matta R, Dvorani E, Wallis C, Hird A, LaBossiere J, Kulkarni G, Kodama R, Carr L, Radomski SB, Saskin R, Herschorn S, Nam RK (2019) Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada. BMJ Open 9(12):e032170. https://doi.org/10.1136/bmjopen-2019-032170
Chughtai BI, Simma-Chiang V, Lee R, Isaacs A, Te AE, Kaplan SA, Sedrakyan A (2015) Trends and utilization of laser prostatectomy in ambulatory surgical procedures for the treatment of benign prostatic hyperplasia in New York State (2000–2011). J Endourol 29(6):700–706
Izard J, Nickel JC (2011) Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 108(1):89–93
Young MJ, Elmussareh M, Morrison T, Wilson JR (2018) The changing practice of transurethral resection of the prostate. Ann R Coll Surg Engl 100(4):326–329
Ingimarsson JP, Isaksson HJ, Sigbjarnarson HP, Gudmundsson J, Geirsson G (2014) Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of prostate. Scand J Urol 48(1):73–78
Doyle RW, Feggetter GY (1935) Endoscopic resection of the prostate. BMJ 26(1):147–151
Botto H, Lebret T, Barré P, Orsoni JL, Hervé JM, Lugagne PM (2001) Electrovaporization of the prostate with the Gyrus device. J Endourol 15(3):313–316
Yang S, Lin WC, Chang HK, Hsu JM, Lin WR, Chow YC, Tsai WK, Lee TA, Lo KY, Chow K, Chen M (2004) Gyrus plasmasect: is it better than monopolar transurethral resection of prostate? Urol Int 73(3):258–261
Alexander CE, Scullion MMF, Omar MI, Yuan Y, Mamoulakis C, N’Dow JMO, Chen C, Lam TBL (2020) Bipolar vs monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction: a Cochrane review. Can Urol Assoc J. https://doi.org/10.5489/cuaj.6464 (online ahead of print)
Fechner G, Schaupp J, Hauser S, Müller SC. Educating transurethral electroresection of the prostate is safe and efficient: is training a risk factor for patients and hospitals? Urologe A 51(11):1572–1575
Furuya S, Furuya R, Ogura H, Araki T, Arita T (2006) A study of 4031 patients of transurethral resection of the prostate performed by one surgeon: learning curve, surgical results and postoperative complications. Hinyokika Kiyo 52(8):609–614
Kailavasan M, Berridge C, Athanasiadis G, Gentzkis A, Rai B, Jain S, Biyani CS, Nabi G (2020) Design, implementation, and evaluation of a novel curriculum to teach transurethral resection of the prostate (TURP): a 3-year experience of urology simulation bootcamp course. World J Urol. https://doi.org/10.1007/s00345-020-03104-3 (Online ahead of print)
Rasyid N, Putra HWK, Birowo P, Wahyudi I, Mochtar CA, Hamid ARAH (2020) TUR-P phantom for resident surgical training: food-based design as a human mimicking model of the prostate. World J Urol. https://doi.org/10.1007/s00345-020-03085-3 (Online ahead of print)
Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066–1096
Muntener M, Aellig S, Kuttel R, Gehrlach C, Hauri D, Strebel RT (2006) Peri-operative morbidity and changes in symptome scores after transurethral prostatectomy in Switzerland: results of an independent assessment of outcome. BJU Int 98(2):381–383
Mayer EK, Kroeze SG, Chopra S, Bottle A, Patel A (2012) Examining the ‘gold standard’: a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes. BJU Int 110(11):1595–1601
Millin T (1932) A short note on endoscopic resection of the prostate. Postgrad Med J 8(83):354–355
Muntener M, Aellig S, Kuettel R, Gehrlach C, Sulser T, Strebel RT (2007) Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol 52(2):510–515
Alloussi SH, Lang C, Eichel R, Alloussi S (2014) Ejaculation-preserving transurethral resection of prostate and bladder neck: short- and long-term results of a new innovative resection technique. J Endourol 28(1):84–89
Gul Z, Chughtai B, Te AE, Thomas D, Kaplan SA (2019) Ejaculatory preserving middle lobe onl-transurethral resection and vaporization of the prostate: 12-year experience. Urology 134:199–202
Eskenazi B, Wyrobek AJ, Sloter E, Kidd SA, Moore L, Young S, Moore D (2003) The association of age and semen quality in healthy men. Hum Reprod 18(2):447–454
Lebdai S, Chevrot A, Doizi S, Pradere B, Delongschamps NB, Benchikh A, Cornu JN, Della Negra E, Fourmarier M, Misraï V, Theveniaud PE, Descazeaud A, Robert G, CTMH-AFU Group (2019) Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment. World J Urol 37(2):299–308
Becher EF, McVary KT (2014) Surgical procedures for BPH/LUTS: Impact on male sexual health. Sex Med Rev 2(1):47–55
Mishriki SF, Grimsley SJ, Lam T, Nabi G, Cohen NP (2012) TURP and sex: patient and partner prospective 12 years follow-up study. BJU Int 109(5):745–750
Brookes ST, Donovan JL, Peters TJ, Abrams P, Neal DE (2002) Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ 324(7345):1059–1061
Koshiba K, Egawa S, Ohori M, Uchida T, Yokoyma E, Shoji K (1995) Does transurethral resection of the prostate pose a risk to life? 22-year outcome. J Urol 153(5):1506–1509
Reich O, Gratzke C, Stief CG (2006) Techniques and long-term results of surgical procedures for BPH. Eur Urol 49(6):970–978
Masumori N, Furuya R, Tanaka Y, Furuya S, Ogura H, Tsukamoto T (2010) The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to urodynamic findings before surgery. BJU Int 105(10):1429–1433
Zwergel U, Wullich B, Lindenmeir U, Rohde V, Zwergel T (1998) Long-term results following transurethral resection of the prostate. Eur Urol 33(5):476–480
Eredics K, Wachabauer D, Röthlin F, Madersbacher S, Schauer I (2018) Reoperation rates and mortality after transurethral and open prostatectomy in a long-term nationwide analysis: have we improved over a decade? Urology 118:152–157
Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG, Urology Section of the Bavarian Working Group for Quality Assurance (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180(1):246–249
Garske GL, Phares OC, Sweetser TH (1949) The status of irrigating fluids for transurethral resection: our experience and a survey of the use of various solutions by others. J Urol 62(3):322–327
De Witt-Foy ME, Gill BC, Ulchaker JC (2019) Cost comparison of benign prostatic hyperplasia treatment options. Curr Urol Rep 20(8):45. https://doi.org/10.1007/s11934-019-0907-3
Pham R, Parke J, Kernen KM (2016) How I do it: same day discharge for transurethral resection of the prostate using Olympus PlasmaButton and PlasmaLoop. Can J Urol 23(5):8491–8494
Salciccia S, Del Giudice D, Maggi M, Eisenberg M, Chung BI, Conti SL et al (2020) Safety and feasibility of outpatient surgery in benign prostatic hyperplasia: a systematic review and meta-analysis. J Endourol. https://doi.org/10.1089/end.2020.0538
Ong WL, Koh TL, Fletcher J, Gruen R, Royce P (2015) Perioperative management of antiplatelets and anticoagulants among patients undergoing elective transurethral resection of the prostate—a single institution experience. J Endourol 29(11):1321–1327
He Q, Yu Y, Gao F (2020) Meta-analysis of the effect of the antithrombotic drugs on perioperative bleeding in BPH surgery. Exp Ther Med 20(4):3807–3815
Fa LX, Zhou WW, Peng HY, Ke ZS, Jian H, Tao Z, Ling ZF, Chang LY, Lu DX, Chao C, Gurioli A, Tuo D, Qi WW (2020) Safety of surgery in benign prostatic hyperplasia patients on antiplatelet or anticoagulant therapy: a systematic review and meta-analysis. Urol J. https://doi.org/10.22037/uj.v16i7.5974
Funding
None.
Author information
Authors and Affiliations
Contributions
RTS, SAK: manuscript writing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Strebel, R.T., Kaplan, S.A. The state of TURP through a historical lens. World J Urol 39, 2255–2262 (2021). https://doi.org/10.1007/s00345-021-03607-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-021-03607-7